Results 21 to 30 of about 1,668 (161)

Molecular Design, Synthesis and Trypanocidal Activity of Dipeptidyl Nitriles as Cruzain Inhibitors. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2015
A series of compounds based on the dipeptidyl nitrile scaffold were synthesized and assayed for their inhibitory activity against the T. cruzi cysteine protease cruzain.
Leandro A A Avelar   +13 more
doaj   +3 more sources

Dissecting a novel allosteric mechanism of cruzain: A computer-aided approach.

open access: yesPLoS ONE, 2019
Trypanosoma cruzi is the causative agent of Chagas disease, a neglected infection affecting millions of people in tropical regions. There are several chemotherapeutic agents for the treatment of this disease, but most of them are highly toxic and ...
Lilian Hernández Alvarez   +3 more
doaj   +6 more sources

Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies

open access: yesMolecules, 2017
Chagas disease (CD) is a neglected disease caused by the parasite Trypanosoma cruzi, which affects underdeveloped countries. The current drugs of choice are nifurtimox and benznidazole, but both have severe adverse effects and less effectivity in chronic
Isidro Palos   +2 more
exaly   +3 more sources

Computational approaches towards the discovery and optimisation of cruzain inhibitors. [PDF]

open access: yesMem Inst Oswaldo Cruz, 2022
The need to develop safer and more efficacious drugs to treat Chagas disease has motivated the search for cruzain inhibitors. Cruzain is the recombinant, truncated version of cruzipain, a cysteine protease from Trypanosoma cruzi with important roles during the parasite life cycle.
Santos VC, Ferreira RS.
europepmc   +4 more sources

Peptidomimetic Vinyl Heterocyclic Inhibitors of Cruzain Effect Antitrypanosomal Activity [PDF]

open access: yesJournal of Medicinal Chemistry, 2020
Cruzain, an essential cysteine protease of the parasitic protozoan, Trypanosoma cruzi, is an important drug target for Chagas disease. We describe here a new series of reversible but time-dependent inhibitors of cruzain, composed of a dipeptide scaffold appended to vinyl heterocycles meant to provide replacements for the irreversible reactive "warheads"
Bala C. Chenna   +12 more
openaire   +2 more sources

Computational Study of the Michaelis Complex Formation and the Effect on the Reaction Mechanism of Cruzain Cysteine Protease [PDF]

open access: yesACS Omega, 2018
Cruzain, a cysteine protease of the papain family, is essential in the development of the protozoan Trypanosoma cruzi, the etiologic agent of Chagas disease, making it an attractive target for developing new drugs. The present paper is aimed at the study
Kemel Arafet   +2 more
doaj   +3 more sources

Antiparasitic Activities of Compounds Isolated from Aspergillus fumigatus Strain Discovered in Northcentral Nigeria. [PDF]

open access: yesAntibiotics (Basel), 2023
In this study, we explored a fungal strain UIAU-3F identified as Aspergillus fumigatus isolated from soil samples collected from the River Oyun in Kwara State, Nigeria. In order to explore its chemical diversity, the fungal strain UIAU-3F was cultured in
Diyaolu OA   +10 more
europepmc   +6 more sources

Lies and Liabilities: Computational Assessment of High-Throughput Screening Hits to Identify Artifact Compounds. [PDF]

open access: yesJ Med Chem, 2023
Hits from high-throughput screening (HTS) of chemical libraries are often false positives due to their interference with assay detection technology. In response, we generated the largest publicly available library of chemical liabilities and developed ...
Alves VM   +10 more
europepmc   +3 more sources

Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitors. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2017
The cysteine protease cruzipain is considered to be a validated target for therapeutic intervention in the treatment of Chagas disease. Anti-trypanosomal activity against the CL Brener strain of T. cruzi was observed in the 0.1 μM to 1 μM range for three
Antonio C B Burtoloso   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy